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Background and Aims: Nonalcoholic Fatty Liver Disease (NAFLD) has been associated with subclinical cardiovascular
disease (CVD) and increased CVD morbidity and mortality. This study was undertaken to 1) ascertain whether NAFLD
patients have abnormal epicardial fat, left ventricular (LV) morphology and function, 2) determine the relative contribution
of epicardial, visceral and hepatic fat to LV dysfunction.
Methods: Nineteen non-diabetic, non-dyslipidemic, non-hypertensive patients with biopsy-proven NAFLD (17 men, age
41±8 years, BMI 26.8±3kg/m2) and 9 healthy controls (5 men, age 30±2 years, BMI 22.5±2kg/m2) underwent
transthoracic echocardiography and cardiac MRI to quantify epicardial fat and cardiac morphology and function. An
abdomen MRI was performed in all subjects to quantify visceral and hepatic fat.
Results: The end-systolic  LV diameter (30.4±3.7 vs 27.2±3.5 mm, p=0.044) and the left atrial area (19.6±3.3 vs 14.9±2.5
cm2, p=0.02) were significantly higher in patients than in controls. Indices of LV diastolic function, namely the early 
diastolic septal and lateral mitral annular velocities, were significantly impaired in NAFLD (9.7±2.6 vs 12.9±2.57 and
13.3±3.5 vs 16.4±1.6 cm/s, vs controls respectively; p<0.03 for both). Similarly, the ratio of early to late diastolic mitral
inflow (E/A ratio) was significantly reduced in patient than in controls (1.2±0.2 vs 1.5±0.2, p=0.004) suggesting an early
diastolic dysfunction. Epicardial fat in NAFLD patients was significantly increased compared to controls, both at
echocardiography and at MRI (5.93±2.25 vs 0.26±0.5 mm, 228.1±112.8 vs 66.8±25.2cm3, respectively, p=0.001). In
NAFLD patients, but not in controls, epicardial fat positively correlated with end-systolic LV diameter (r=0.46, p=0.046)
and inversely with the ejection fraction (EF). Epicardial fat was tightly related to visceral fat (r=0.58, p=0.03), but not to
hepatic fat. Visceral fat inversely correlated with EF, whereas hepatic fat directly correlated with the end systolic LV
volume (r=0.63, p=0.004).
Conclusions: Non diabetic, non-dyslipidemic, normotensive NAFLD patients show early signs of both diastolic and
systolic LV dysfunction. Epicardial, visceral and hepatic fat are increased and associated with parameters of early systolic
dysfunction.
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